Tim McCarthy
Analyst
LifeSci Advisors
Equibles does not estimate personal net worth.
About Tim McCarthy
Tim McCarthy is recorded as Analyst at LifeSci Advisors. Tim McCarthy has spoken on 8 earnings calls across 2 companies, most recently for Relmada Therapeutics, Inc. on September 30, 2024. Those appearances were for Relmada Therapeutics, Inc. (RLMD) and BioLineRx Ltd. (BLRX). The companies whose calls Tim McCarthy spoke on are classified in the Healthcare sector.
Tim McCarthy on recent calls
“This afternoon, Relmada issued a press release providing a business update and outlining its financial results for the three months ended September 30, 2024. Please note that certain information discussed on the call today is covered under the Safe Harbor provision of the Private Securities Litigation Reform Act.”
“With me on today's call are Dr. Sergio Traversa, Chief Executive Officer; and Maged Shenouda, Chief Financial Officer. This afternoon, Relmada issued a press release providing a business update and announcing financial results for the quarter ended June 30, 2024.”
“With me on today's call are our Chief Executive Officer, Sergio Traversa, and Chief Financial Officer, Maged Shenouda. This afternoon, Relmada issued a press release providing a business update announcing financial results for the 3 months ended March 31, 2024.”
“And thank you all for joining us this afternoon. With me on today's call are Chief Executive Officer, Sergio Traversa, and Chief Financial Officer, Maged Shenouda; and Dr. Cedric O'Gorman, Chief Medical Officer.”
“Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements. All statements in this conference call, other than historical facts, are indeed forward-looking statements.”
Affiliation history
-
LifeSci Advisors
Analyst
Source not stated
Current
Company network
BioLineRx Ltd.
BLRX
Biotechnology · Healthcare
2 appearances
Latest appearance 2022-06-30
View calls and events